86 related articles for article (PubMed ID: 22975371)
1. IDH1 mutations disrupt blood, brain, and barriers.
Shih AH; Levine RL
Cancer Cell; 2012 Sep; 22(3):285-7. PubMed ID: 22975371
[TBL] [Abstract][Full Text] [Related]
2. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.
Sasaki M; Knobbe CB; Munger JC; Lind EF; Brenner D; Brüstle A; Harris IS; Holmes R; Wakeham A; Haight J; You-Ten A; Li WY; Schalm S; Su SM; Virtanen C; Reifenberger G; Ohashi PS; Barber DL; Figueroa ME; Melnick A; Zúñiga-Pflücker JC; Mak TW
Nature; 2012 Aug; 488(7413):656-9. PubMed ID: 22763442
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody specific for IDH1 R132H mutation.
Capper D; Zentgraf H; Balss J; Hartmann C; von Deimling A
Acta Neuropathol; 2009 Nov; 118(5):599-601. PubMed ID: 19798509
[TBL] [Abstract][Full Text] [Related]
4. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
5. Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.
Takano S; Tian W; Matsuda M; Yamamoto T; Ishikawa E; Kaneko MK; Yamazaki K; Kato Y; Matsumura A
Brain Tumor Pathol; 2011 Apr; 28(2):115-23. PubMed ID: 21344322
[TBL] [Abstract][Full Text] [Related]
6. Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.
Inoue S; Li WY; Tseng A; Beerman I; Elia AJ; Bendall SC; Lemonnier F; Kron KJ; Cescon DW; Hao Z; Lind EF; Takayama N; Planello AC; Shen SY; Shih AH; Larsen DM; Li Q; Snow BE; Wakeham A; Haight J; Gorrini C; Bassi C; Thu KL; Murakami K; Elford AR; Ueda T; Straley K; Yen KE; Melino G; Cimmino L; Aifantis I; Levine RL; De Carvalho DD; Lupien M; Rossi DJ; Nolan GP; Cairns RA; Mak TW
Cancer Cell; 2016 Aug; 30(2):337-348. PubMed ID: 27424808
[TBL] [Abstract][Full Text] [Related]
7. IDH1 mutations in gliomas: when an enzyme loses its grip.
Frezza C; Tennant DA; Gottlieb E
Cancer Cell; 2010 Jan; 17(1):7-9. PubMed ID: 20129244
[TBL] [Abstract][Full Text] [Related]
8. IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo.
Bralten LB; Kloosterhof NK; Balvers R; Sacchetti A; Lapre L; Lamfers M; Leenstra S; de Jonge H; Kros JM; Jansen EE; Struys EA; Jakobs C; Salomons GS; Diks SH; Peppelenbosch M; Kremer A; Hoogenraad CC; Smitt PA; French PJ
Ann Neurol; 2011 Mar; 69(3):455-63. PubMed ID: 21446021
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
[TBL] [Abstract][Full Text] [Related]
10. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
Preusser M; Wöhrer A; Stary S; Höftberger R; Streubel B; Hainfellner JA
J Neuropathol Exp Neurol; 2011 Aug; 70(8):715-23. PubMed ID: 21760534
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.
Thirant C; Varlet P; Lipecka J; Le Gall M; Broussard C; Chafey P; Studler JM; Lacombe J; Lions S; Guillaudeau A; Camoin L; Daumas-Duport C; Junier MP; Chneiweiss H
Proteomics; 2011 Nov; 11(21):4139-54. PubMed ID: 21898821
[TBL] [Abstract][Full Text] [Related]
12. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.
Kaneko MK; Tian W; Takano S; Suzuki H; Sawa Y; Hozumi Y; Goto K; Yamazaki K; Kitanaka C; Kato Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):608-13. PubMed ID: 21352804
[TBL] [Abstract][Full Text] [Related]
14. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.
Olar A; Raghunathan A; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Goodman JC; Fuller GN
Ann Diagn Pathol; 2012 Jun; 16(3):161-70. PubMed ID: 22197544
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic differentiation of embryonic stem cells.
Orlovskaya I; Schraufstatter I; Loring J; Khaldoyanidi S
Methods; 2008 Jun; 45(2):159-67. PubMed ID: 18593612
[TBL] [Abstract][Full Text] [Related]
16. Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models.
Lensch MW; Daley GQ
Curr Top Dev Biol; 2004; 60():127-96. PubMed ID: 15094298
[TBL] [Abstract][Full Text] [Related]
17. Histamine-producing cell-stimulating factor (HCSF) and interleukin-3 (IL3).
Dy M; Lebel B; Schneider E; Gastinel L
Ann Inst Pasteur Immunol; 1986; 137D(2):223-32. PubMed ID: 3541967
[No Abstract] [Full Text] [Related]
18. Tipping Clonal Hematopoiesis into Transformation.
Karlsson S
N Engl J Med; 2018 Jul; 379(3):295-296. PubMed ID: 30021097
[No Abstract] [Full Text] [Related]
19. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
20. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
